Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$987M |
| 2 |
Salesforce
CRM
|
+$660M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$586M |
| 4 |
HCA Healthcare
HCA
|
+$513M |
| 5 |
Netflix
NFLX
|
+$372M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$815M |
| 2 |
Incyte
INCY
|
+$811M |
| 3 |
NVIDIA
NVDA
|
+$514M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$493M |
| 5 |
MetLife
MET
|
+$366M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.63% |
| 2 | Technology | 14.62% |
| 3 | Industrials | 7.95% |
| 4 | Healthcare | 7.93% |
| 5 | Energy | 7.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5551
Mitek Systems
MITK
$877M
| $63K | ﹤0.01% |
5,736
-160
| -3% | -$1.56K |
|
5552
PUT
Teladoc Health
TDOC
$1.24B
| $63K | ﹤0.01% |
+2,500
| New | +$62.9K |
|
5553
Titan International
TWI
$445M
| $63K | ﹤0.01% |
5,472
+2,128
| +64% | +$22.6K |
|
5554
Inspire International ETF
WWJD
$572M
| $63K | ﹤0.01% |
+2,265
| New | +$63.2K |
|
5555
Aclaris Therapeutics
ACRS
$851M
| $62K | ﹤0.01% |
5,970
+1,435
| +32% | +$13K |
|
|
AGEN
5556
Agenus
AGEN
$329M
| $62K | ﹤0.01% |
1,927
+1,051
| +120% | +$33.6K |
|
5557
Amplify AI Powered Equity ETF
AIEQ
$125M
| $62K | ﹤0.01% |
1,959
-20
| -1% | -$583 |
|
5558
Amprius Technologies
AMPX
$1.83B
| $62K | ﹤0.01% |
8,699
+2,250
| +35% | +$19.3K |
|
5559
InfraCap MLP ETF
AMZA
$484M
| $62K | ﹤0.01% |
1,856
+1,200
| +183% | +$38.7K |
|
|
AXDX
5560
DELISTED
Accelerate Diagnostics
AXDX
| $62K | ﹤0.01% |
7,692
-8
| -0.1% | -$60 |
|
5561
Planet Labs
PL
$8.8B
| $62K | ﹤0.01% |
19,088
-3,100
| -14% | -$12.3K |
|
5562
RxSight
RXST
$287M
| $62K | ﹤0.01% |
2,168
-91
| -4% | -$2.02K |
|
5563
Stoneridge
SRI
$205M
| $62K | ﹤0.01% |
3,319
+1,362
| +70% | +$23.9K |
|
|
GXDW
5564
Global X Funds Global X Dorsey Wright Thematic ETF
GXDW
$6.46M
| $62K | ﹤0.01% |
2,335
| – | – |
|
|
SOVO
5565
DELISTED
Sovos Brands, Inc. Common Stock
SOVO
| $62K | ﹤0.01% |
3,200
+320
| +11% | +$5.77K |
|
|
EQRX
5566
DELISTED
EQRx, Inc. Common Stock
EQRX
| $62K | ﹤0.01% |
33,290
+22,025
| +196% | +$39.4K |
|
|
ACB
5567
Aurora Cannabis
ACB
$233M
| $61K | ﹤0.01% |
11,650
-501
| -4% | -$2.95K |
|
|
GBIO
5568
DELISTED
Generation Bio
GBIO
| $61K | ﹤0.01% |
1,108
+200
| +22% | +$9.18K |
|
5569
Inspire Small/Mid Cap Impact ETF
ISMD
$347M
| $61K | ﹤0.01% |
1,905
-171
| -8% | -$5.23K |
|
5570
Janus International
JBI
$697M
| $61K | ﹤0.01% |
5,751
+705
| +14% | +$6.6K |
|
|
NHS
5571
Neuberger High Yield Strategies Fund Inc
NHS
$255M
| $61K | ﹤0.01% |
8,207
-10
| -0.1% | -$83 |
|
5572
Newmark Group
NMRK
$2.76B
| $61K | ﹤0.01% |
9,807
-4,534
| -32% | -$27.9K |
|
5573
Senseonics Holdings Inc
SENS
$413M
| $61K | ﹤0.01% |
4,015
-1,292
| -24% | -$17.7K |
|
5574
Westlake Chemical Partners
WLKP
$765M
| $61K | ﹤0.01% |
2,816
-1,000
| -26% | -$21.9K |
|
5575
BNY Mellon US Small Cap Core Equity ETF
BKSE
$90.7M
| $60K | ﹤0.01% |
2,100
-96
| -4% | -$2.59K |
|
Similar funds
Royal Bank of Canada's Q2 2023 Portfolio in Review
As of Q2 2023, Royal Bank of Canada held 8,037 positions worth $381B, up 7.7% from $354B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Royal Bank of Canada's Q2 2023 filing shows 675 new, 3,796 increased, 2,511 reduced and 409 closed positions. Its largest new stake was ATS Corp: 3,088,815 shares worth $142M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $815M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 19% a quarter earlier, followed by Technology and Industrials.
- Royal Bank of Canada's largest Q2 2023 buy was ATS Corp: 3,088,815 shares worth $142M.
- Royal Bank of Canada added most to Thermo Fisher Scientific in Q2 2023, an estimated $987M increase.
- Royal Bank of Canada's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $815M.
- Royal Bank of Canada fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $150M.
- Royal Bank of Canada's ten largest holdings make up 19% of its $381B portfolio in Q2 2023.
- Royal Bank of Canada opened 675 new positions and closed 409 in Q2 2023.
- Royal Bank of Canada's portfolio value rose 7.7% quarter-over-quarter to $381B.
Based on Royal Bank of Canada's 13F filing for Q2 2023, filed 14 Aug 2023.